Manning Paul B Insider Trades

Insider Trading History

Track insider trading activity for Manning Paul B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $21.2k 2,199 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.6k 2,199 shares
$10.30
$9.64
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $308k 32,000 shares
Last Trade
Jun 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 32,000 shares
$9.08
$9.64
Liquidia
Liquidia LQDA
Director
Holding Value $37M 475,465 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422k 5,882 shares
$71.80
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $68.4M 879,210 shares
Last Trade
Jun 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.8M 200,000 shares
$63.91
$77.75
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $44.5k 4,618 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.6k 4,618 shares
$4.90
$9.64
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $26.6M 2,763,527 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 550,458 shares
$5.45
$9.64
Liquidia
Liquidia LQDA
Director
Holding Value $36.5M 469,583 shares
Last Trade
Feb 11, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.35M 55,116 shares
$42.63
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $0 0 shares
Last Trade
Feb 11, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.35M 55,116 shares
$42.63
$77.75
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $22.4M 3,958,189 shares
Last Trade
Nov 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24M 5,157,677 shares
$4.66
$5.66
Liquidia
Liquidia LQDA
Director
Holding Value $39.3M 505,058 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.45M 328,268 shares
$28.78
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $59M 759,096 shares
Last Trade
Aug 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.2M 188,232 shares
$27.62
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $73.7M 947,328 shares
Last Trade
Aug 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.31M 154,337 shares
$27.94
$77.75
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $21.3M 2,213,069 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 1,070,663 shares
$4.67
$9.64
Liquidia
Liquidia LQDA
Director
Holding Value $3.01M 38,755 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 18,396 shares
$13.59
$77.75
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $137k 14,240 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.3k 14,240 shares
$4.94
$9.64
Taysha Gene Therapies
Taysha Gene Therapies TSHA
10% owner
Holding Value $16.2M 2,841,704 shares
Last Trade
May 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.06M 750,000 shares
$2.75
$5.70
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $12.6M 1,303,752 shares
Last Trade
Dec 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.5M 1,250,000 shares
$6.00
$9.64
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $146M 25,828,094 shares
Last Trade
Nov 26, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$500k 450,000 shares
$1.11
$5.66
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $149M 26,278,094 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.1M 45,842,696 shares
$1.05
$5.66
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$5.19M 2,675,611 shares
$1.94
$5.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up